Healthcare Market Research Expert

Albumin (Excipient) Market : A Brief Report on the Steadily Growing and Technologically Advancing

Press Release   •   Feb 29, 2016 04:28 EST

Transparency Market Research (TMR), a market intelligence and research firm, has recently announced the publication of a market study on the global albumin market, estimating it to expand at a CAGR of 2.30% during the period from 2014 to 2020 and reach US$828.2 mn by the end of 2020, from a market value of US$704.9 mn in 2013.The research report, titled “Albumin Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2020”, states that the improved stability of products containing albumin as an excipient has driven the demand for albumin extensively in the global arena. Apart from this, the enhancement in molecular separation and protein purification technologies, together with increasing usage of recombinant albumin, is expected to fuel the global albumin market significantly over the forecast period.

Get Report Sample and Customization:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3984

The report also discusses the challenges faced by the albumin market across the world. Strict rules and regulations regarding the usage of albumin, high cost associated with it, and the concerns pertaining to the impact of albumin on human health are the major issues that the global albumin market is currently dealing with. The rising demand for serum-free, customized, and chemically defined media is likely to hamper the global albumin market over the forecast period.

According to the report, the global albumin market is evaluated on three front: type, application, and regional distribution. Based on type, the market is segmented into the bovine serum albumin, human serum albumin, and recombinant albumin markets. The human serum albumin market dominated the overall albumin market, generating a revenue of US$476.7 mn in 2013. The market segment is likely to retain its position, expanding at a CAGR of 2.20% between 2014 and 2020 and reach US$557 mn by 2020. However, the recombinant albumin market is likely to register the fastest growth, at a CAGR of 2.70% over the forecast period.

The report states that the global market for albumin is classified into drug formulation and delivery, component of medium, and vaccines on the basis of application. Among these, the drug formulation and delivery market is estimated to post the fastest CAGR of 2.40% from 2014 to 2020 and reach US$395.9 mn by the end of the forecast period.North America, Asia Pacific, Europe, and the Rest of the World are the key regional markets for albumin in the global arena, cites the research report. North America occupies the leading position in the worldwide albumin market, wherein the U.S. accounts for the largest share. The presence of a huge pharmaceutical industry, which is one of the major end users of albumin, is the main reason for the dominance of North America in the global albumin market.

Asia Pacific and Europe also contribute significantly to the global albumin market. China is the biggest market for albumin in the Asia Pacific region, notes the research study.Octapharma, CSL Behring, InVitria, HiMedia Laboratories, MedxBio Pte. Ltd., Novozymes, Mitsubishi Tanabe Pharma, Sigma-Aldrich Corp., RayBiotech Inc., and Thermo Fisher Scientific are some of the major companies operating in the global market for albumin, states the market report.

Full Research Report on Global Albumin Market with detailed figures and segmentation at: http://www.transparencymarketresearch.com/albumin-market.html